Peptilogics: Valuation, Funding & Investors
Peptilogics is a clinical-stage biotechnology company developing transformative surgical therapeutics to effectively treat and prevent serious medical device infections. The company's lead candidate, zaloganan (PLG0206), is an investigational treatment for prosthetic joint infections currently in clinical development.
Leadership & Board
- Current Number of Employees
- 22
- Current LinkedIn Followers
- 4,506
Latest Estimated Valuation
- Total Amount Raised
- $78M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $78M
- Latest Funding Round
- Series B
Employee Trend
Peptilogics had 22 employees as of November 2, 2026. The number of employees increased by 0 (0.00%) week-over-week.
22Latest Employee Count
0(0.00%)Week-Over-Week Change
Social Trend
Peptilogics had 4,506 followers as of November 2, 2026. The number of followers increased by 7 (0.16%) week-over-week.
4,506Latest Followers Count
7(0.16%)Week-Over-Week Change
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Oct 16, 2025 | Series B | $78.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| Founders Fund | Series B |
| AMR Action Fund | Series B |
| Narya Capital | Series B |
| Presight Capital | Series B |
| Thiel Bio | Series B |
| Beyond Ventures | Series B |
Similar Companies
A snapshot of private companies similar to Peptilogics, helping you discover and navigate related company profiles.
Related News and Analysis
